A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving Pulmonary Function Following Radiation Therapy
- Status
- COMPLETED
- Phase
- NA
Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
- Status
- COMPLETED
- Phase
- PHASE2
Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
- Status
- WITHDRAWN
- Phase
- NA
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia
- Status
- COMPLETED
- Phase
- N/A
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab + CVA21 in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
- Status
- COMPLETED
- Phase
- PHASE2
Acquired Resistant Mechanism of the First-generation EGFR TKIs
- Status
- UNKNOWN
- Phase
- N/A
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
- Status
- UNKNOWN
- Phase
- N/A
Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study
- Status
- COMPLETED
- Phase
- N/A
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Food Reward in Cachexia Induced by Acute or Chronic Disease
- Status
- TERMINATED
- Phase
- N/A
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA